Trade NeoGenomics - NEOus CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 9.57 |
| Open | 9.09 |
| 1-Year Change | -42.14% |
| Day's Range | 8.96 - 9.51 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 28, 2025 | 9.57 | 0.26 | 2.79% | 9.31 | 9.63 | 8.98 |
| Mar 27, 2025 | 9.44 | 0.10 | 1.07% | 9.34 | 9.64 | 9.27 |
| Mar 26, 2025 | 9.36 | -0.46 | -4.68% | 9.82 | 9.85 | 9.35 |
| Mar 25, 2025 | 9.91 | -0.06 | -0.60% | 9.97 | 10.17 | 9.83 |
| Mar 24, 2025 | 10.11 | 0.15 | 1.51% | 9.96 | 10.33 | 9.79 |
| Mar 21, 2025 | 9.80 | 0.13 | 1.34% | 9.67 | 9.99 | 9.51 |
| Mar 20, 2025 | 9.88 | 0.15 | 1.54% | 9.73 | 9.92 | 9.68 |
| Mar 19, 2025 | 9.90 | 0.34 | 3.56% | 9.56 | 10.12 | 9.31 |
| Mar 18, 2025 | 9.55 | -0.13 | -1.34% | 9.68 | 9.72 | 9.33 |
| Mar 17, 2025 | 9.78 | 0.05 | 0.51% | 9.73 | 10.10 | 9.64 |
| Mar 14, 2025 | 9.77 | 0.30 | 3.17% | 9.47 | 9.93 | 9.46 |
| Mar 13, 2025 | 9.46 | -0.54 | -5.40% | 10.00 | 10.07 | 9.36 |
| Mar 12, 2025 | 10.18 | -0.65 | -6.00% | 10.83 | 10.85 | 10.03 |
| Mar 11, 2025 | 10.83 | 1.79 | 19.80% | 9.04 | 10.89 | 8.96 |
| Mar 10, 2025 | 9.03 | -0.73 | -7.48% | 9.76 | 9.89 | 9.03 |
| Mar 7, 2025 | 10.05 | -0.04 | -0.40% | 10.09 | 10.60 | 9.95 |
| Mar 6, 2025 | 10.49 | 0.81 | 8.37% | 9.68 | 10.59 | 9.68 |
| Mar 5, 2025 | 10.10 | 0.89 | 9.66% | 9.21 | 10.10 | 9.21 |
| Mar 4, 2025 | 9.27 | -0.03 | -0.32% | 9.30 | 9.41 | 8.93 |
| Mar 3, 2025 | 9.52 | -0.33 | -3.35% | 9.85 | 10.05 | 9.51 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
NeoGenomics Company profile
About NeoGenomics, Inc.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. It offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, NeoGenomics, Inc. revenues increased 9% to $484.3M. Net loss totaled $8.3M vs. income of $4.2M. Revenues reflect Clinical Services segment increase of 6% to $404.2M, Pharma Services segment increase of 29% to $80.2M. Net loss reflects General and administrative increase of 38% to $167.2M (expense), Sales and marketing increase of 31% to $62.6M (expense).
Equity composition
Common Stock $0.001 Par, 03/12, 100M auth., 43,236,498. issd. Insiders own approx. 46.49%.
| Industry: | Medical & Diagnostic Laboratories |
9490 Neogenomics Way
FORT MYERS
FLORIDA 33912
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com